RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration

Nathan I. Cherny; Urani Dafni; Jan Bogaerts; Nicola J. Latino; George Pentheroudakis; Jean-Yves Douillard; Josep Tabernero; Christoph Zielinski; Martine J. Piccart; Elisabeth G. E. de Vries

doi:10.1093/jnci/djy029

RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration

Nathan I. Cherny^*, Urani Dafni, Jan Bogaerts, Nicola J. Latino, George Pentheroudakis, Jean-Yves Douillard, Josep Tabernero, Christoph Zielinski, Martine J. Piccart, Elisabeth G. E. de Vries

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Citation (Scopus)

Original language	English
Article number	029
Pages (from-to)	1142-1143
Number of pages	2
Journal	Journal of the National Cancer Institute
Volume	110
Issue number	10
DOIs	https://doi.org/10.1093/jnci/djy029
Publication status	Published - Oct-2018

Keywords

ESMO-MAGNITUDE
SCALE

Access to Document

10.1093/jnci/djy029

Handle.net

Persistent link

Embargoed Document

RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
Final publisher's version, 595 KB
Request copy

Cite this

Cherny, N. I., Dafni, U., Bogaerts, J., Latino, N. J., Pentheroudakis, G., Douillard, J.-Y., Tabernero, J., Zielinski, C., Piccart, M. J., & de Vries, E. G. E. (2018). RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration. Journal of the National Cancer Institute , 110(10), 1142-1143. Article 029. https://doi.org/10.1093/jnci/djy029

@article{9ebd5a2d242541f8bdb8e71f6c89eb4c,

title = "RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration",

keywords = "ESMO-MAGNITUDE, SCALE",

author = "Cherny, {Nathan I.} and Urani Dafni and Jan Bogaerts and Latino, {Nicola J.} and George Pentheroudakis and Jean-Yves Douillard and Josep Tabernero and Christoph Zielinski and Piccart, {Martine J.} and {de Vries}, {Elisabeth G. E.}",

year = "2018",

month = oct,

doi = "10.1093/jnci/djy029",

language = "English",

volume = "110",

pages = "1142--1143",

journal = "Journal of the National Cancer Institute ",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration

AU - Cherny, Nathan I.

AU - Dafni, Urani

AU - Bogaerts, Jan

AU - Latino, Nicola J.

AU - Pentheroudakis, George

AU - Douillard, Jean-Yves

AU - Tabernero, Josep

AU - Zielinski, Christoph

AU - Piccart, Martine J.

AU - de Vries, Elisabeth G. E.

PY - 2018/10

Y1 - 2018/10

KW - ESMO-MAGNITUDE

KW - SCALE

U2 - 10.1093/jnci/djy029

DO - 10.1093/jnci/djy029

M3 - Comment/Letter to the editor

SN - 0027-8874

VL - 110

SP - 1142

EP - 1143

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 10

M1 - 029

ER -